Lilly dévoile des données de validation de principe concernant l’anticorps neutralisant LY-CoV555 pour le traitement de la COVID-19 en contexte ambulatoire

NEXT STORY
Novartis Tafinlar® + Mekinist® demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
PREV STORY
Trillium Closes US$150 Million Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gold River Productions, Inc. (GRPS) Appoints Michael Berkowitz to spearhead the Rejuvenation Division with “StemSpa”

author_avatar
NASDAQ Market News

OncoMed to Present Clinical Data for Wnt Inhibitors at the ESMO 2016 Congress

REDWOOD CITY, Calif., Sept. 29, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) announced ...

author_avatar
NASDAQ Market News

Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration

Agreement accelerates development of Adaptimmune’s lead T-cell therapy targeting NY-ESO-1 toward pivotal trialsCreates opportunity ...

author_avatar
NASDAQ Market News